Xtant Medical Holdings, Inc. (XTNT) SEC filings

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value

$0.28−0.00 (-0.94%)

Close on Nov 12, 2026Market cap $38.62MP/E –Yield –

SEC filings

40 of Xtant Medical's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Jun 30, 2026	Aug 11, 2026	SEC EDGAR
Current report	8-K	Aug 11, 2026	Aug 11, 2026	SEC EDGAR
Current report	8-K	Aug 7, 2026	Aug 7, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jun 23, 2026	Jun 23, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 13, 2026	SEC EDGAR
Current report	8-K	May 13, 2026	May 13, 2026	SEC EDGAR
Current report	8-K	Apr 10, 2026	Apr 13, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 31, 2026	SEC EDGAR
Current report	8-K	Mar 31, 2026	Mar 31, 2026	SEC EDGAR
Current report	8-K	Mar 2, 2026	Mar 2, 2026	SEC EDGAR
Current report	8-K	Jan 15, 2026	Jan 16, 2026	SEC EDGAR
Current report	8-K	Dec 1, 2025	Dec 3, 2025	SEC EDGAR
Current report	8-K	Nov 10, 2025	Nov 10, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Nov 7, 2025	Nov 10, 2025	SEC EDGAR
Proxy statement	DEF 14A	Sep 15, 2025	Sep 15, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 12, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 12, 2025	SEC EDGAR
Current report	8-K	Aug 8, 2025	Aug 8, 2025	SEC EDGAR
Current report	8-K	Aug 1, 2025	Aug 4, 2025	SEC EDGAR
Current report	8-K	Jul 7, 2025	Jul 8, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 12, 2025	SEC EDGAR
Current report	8-K	May 12, 2025	May 12, 2025	SEC EDGAR
Current report	8-K	Apr 15, 2025	Apr 16, 2025	SEC EDGAR
Current report	8-K	Apr 10, 2025	Apr 11, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 6, 2025	SEC EDGAR
Current report	8-K	Mar 6, 2025	Mar 6, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Nov 12, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Sep 3, 2024	Sep 3, 2024	SEC EDGAR
Current report	8-K	Aug 7, 2024	Aug 8, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Jul 23, 2024	Jul 24, 2024	SEC EDGAR
Proxy statement	DEF 14A	Jun 10, 2024	Jun 10, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 15, 2024	SEC EDGAR
Current report	8-K	May 15, 2024	May 15, 2024	SEC EDGAR
Annual report	10-K	Dec 31, 2023	Apr 1, 2024	SEC EDGAR
Current report	8-K	Apr 1, 2024	Apr 1, 2024	SEC EDGAR
Current report	8-K	Mar 7, 2024	Mar 7, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Xtant Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Feb 14, 2018
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is XTNT.

Compare: XTNT vs SIBN · XTNT vs TELA · XTNT vs ANIK · XTNT vs CARL · XTNT vs IRMD

Revenue growth-14.3% · median 11.0%

Gross margin59.4% · median 75.5%

Operating margin-9.6% · median -8.3%

Net margin-10.2% · median -6.9%

Company	Revenue	Growth
SIBN	$213.60M	+15.3%
ANIK	$123.43M	+9.4%
XTNT	$109.53M	-14.3%
IRMD	$89.34M	+11.0%
TELA	$78.18M	+1.5%
CARL	$71.78M	+60.4%

Company

Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 151
Held by institutions: 100.0%
Auditor: GRANT THORNTON LLP
SEC CIK: 1453593

Advertisement
300 × 250

See a number that looks wrong?